Skip to main content

Advertisement

SpringerLink
Log in

Emergency Neurological Life Support: Intracerebral Hemorrhage

  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Intracerebral hemorrhage (ICH) is a subset of stroke due to spontaneous bleeding within the parenchyma of the brain. It is potentially lethal, and survival depends on ensuring an adequate airway, proper diagnosis, and early management of several specific issues such as blood pressure, coagulopathy reversal, and surgical hematoma evacuation for appropriate patients. ICH was chosen as an Emergency Neurological Life Support (ENLS) protocol because intervention within the first hours may improve outcome, and it is critical to have site-specific protocols to drive care quickly and efficiently.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hemphill JC III, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–60.

    Article  PubMed  Google Scholar 

  2. Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. International Journal of Stroke: Official Journal of the International Stroke Society. 2014;9:840–55.

    Article  Google Scholar 

  3. Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293–8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke. 2004;35:502–6.

    Article  PubMed  Google Scholar 

  5. Kothari R, Brott T, Broderick J, Barsan W, Sauerbeck L, Zuccarello M. The ABCs of measuring intracerebral hemorrhage volume. Stroke. 1996;27:1304–5.

    Article  CAS  PubMed  Google Scholar 

  6. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.

    Article  CAS  PubMed  Google Scholar 

  7. Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68:889–94.

    Article  CAS  PubMed  Google Scholar 

  8. Kim J, Smith A, Hemphill JC III, et al. Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol. 2008;29:520–5.

    Article  CAS  PubMed  Google Scholar 

  9. Wada R, Aviv RI, Fox AJ, et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257–62.

    Article  PubMed  Google Scholar 

  10. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.

    Article  PubMed  Google Scholar 

  11. Hemphill JC III, Farrant M, Neill TA Jr. Prospective validation of the ICH Score for 12-month functional outcome. Neurology. 2009;73:1088–94.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.

    Article  CAS  PubMed  Google Scholar 

  13. Rost NS, Smith EE, Chang Y, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke. 2008;39:2304–9.

    Article  PubMed  Google Scholar 

  14. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med. 1995;23:950–4.

    Article  CAS  PubMed  Google Scholar 

  15. Hemphill JC III, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004;35:1130–4.

    Article  PubMed  Google Scholar 

  16. Hemphill JC III, White DB. Clinical nihilism in neuroemergencies. Emerg Med Clin North Am. 2009;27:27–37 vii-viii.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–81.

    Article  CAS  PubMed  Google Scholar 

  18. Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059–64.

    Article  CAS  PubMed  Google Scholar 

  19. Jauch EC, Lindsell CJ, Adeoye O, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061–5.

    Article  PubMed  Google Scholar 

  20. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997;28:2370–5.

    Article  CAS  PubMed  Google Scholar 

  21. Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology. 1999;52:266–72.

    Article  CAS  PubMed  Google Scholar 

  22. Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804–10.

    Article  CAS  PubMed  Google Scholar 

  23. Antihypertensive Treatment of Acute Cerebral Hemorrhage Investigators.  Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38:637–48.

  24. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391–9.

    Article  PubMed  Google Scholar 

  25. Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. The New England Journal of Medicine. 2013;368:2355–65.

    Article  CAS  PubMed  Google Scholar 

  26. Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. The New England Journal Of Medicine. 2016;375:1033–43.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Guidelines on oral anticoagulation. third edition. Br J Haematol. 1998;101:374–87.

    Article  Google Scholar 

  28. Frontera JA, Lewin JJ III, Rabinstein AA, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24:6–46.

    Article  CAS  PubMed  Google Scholar 

  29. Hanley JP. Warfarin reversal. J Clin Pathol. 2004;57:1132–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234–43.

    CAS  PubMed  Google Scholar 

  31. Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465–70.

    Article  CAS  PubMed  Google Scholar 

  32. Steiner T, Poli S, Griebe M, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 2016;15:566–73.

    Article  CAS  PubMed  Google Scholar 

  33. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. The New England Journal Of Medicine. 2008;358:2127–37.

    Article  CAS  PubMed  Google Scholar 

  34. Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke. 2006;37:2165–7.

    Article  CAS  PubMed  Google Scholar 

  35. Naidech AM, Bernstein RA, Levasseur K, et al. Platelet activity and outcome after intracerebral hemorrhage. Ann Neurol. 2009;65:352–6.

    Article  PubMed  Google Scholar 

  36. Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009;72:1397–402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Thompson BB, Bejot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75:1333–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387:2605–13.

    Article  PubMed  Google Scholar 

  39. Pollack CV Jr, Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. The New England Journal Of Medicine. 2015;373:511–20.

    Article  CAS  PubMed  Google Scholar 

  40. Dager WE, Gosselin RC, Roberts AJ. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity. Crit Care Med. 2013;41:e42–6.

    Article  PubMed  Google Scholar 

  41. Lazo-Langner A, Lang ES, Douketis J. Clinical review: clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care. 2013;17:230.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124:1573–9.

    Article  CAS  PubMed  Google Scholar 

  43. Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med Rev. 2007;21:37–48.

    Article  PubMed  Google Scholar 

  44. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.

    Article  PubMed  Google Scholar 

  45. Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382:397–408.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Auer LM, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg. 1989;70:530–5.

    Article  CAS  PubMed  Google Scholar 

  47. Niizuma H, Shimizu Y, Yonemitsu T, Nakasato N, Suzuki J. Results of stereotactic aspiration in 175 cases of putaminal hemorrhage. Neurosurgery. 1989;24:814–9.

    Article  CAS  PubMed  Google Scholar 

  48. Vespa P, McArthur D, Miller C, et al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care. 2005;2:274–81.

    Article  PubMed  Google Scholar 

  49. Firsching R, Huber M, Frowein RA. Cerebellar haemorrhage: management and prognosis. Neurosurg Rev. 1991;14:191–4.

    Article  CAS  PubMed  Google Scholar 

  50. Kirollos RW, Tyagi AK, Ross SA, van Hille PT, Marks PV. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery. 2001;49:1378–86 discussion 86-7.

    Article  CAS  PubMed  Google Scholar 

  51. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635–40.

    Article  CAS  PubMed  Google Scholar 

  52. Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354–61.

    Article  CAS  PubMed  Google Scholar 

  53. Vespa PM. Intensive glycemic control in traumatic brain injury: what is the ideal glucose range? Crit Care. 2008;12:175.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Nyquist P, Bautista C, Jichici D, et al. Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care. 2016;24:47–60.

    Article  PubMed  Google Scholar 

  55. Chambers IR, Banister K, Mendelow AD. Intracranial pressure within a developing intracerebral haemorrhage. Br J Neurosurg. 2001;15:140–1.

    Article  CAS  PubMed  Google Scholar 

  56. Fernandes HM, Siddique S, Banister K, et al. Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. Acta Neurochir Suppl. 2000;76:463–6.

    CAS  PubMed  Google Scholar 

  57. Kamel H, Hemphill JC III. Characteristics and sequelae of intracranial hypertension after intracerebral hemorrhage. Neurocrit Care. 2012;17:172–6.

    Article  CAS  PubMed  Google Scholar 

  58. Ziai WC, Torbey MT, Naff NJ, et al. Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis. 2009;27:403–10.

    Article  PubMed  PubMed Central  Google Scholar 

  59. De Herdt V, Dumont F, Henon H, et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology. 2011;77:1794–800.

    Article  PubMed  Google Scholar 

  60. Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43:1175–80.

    Article  PubMed  Google Scholar 

  61. Messe SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11:38–44.

    Article  CAS  PubMed  Google Scholar 

  62. Naidech AM, Garg RK, Liebling S, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40:3810–5.

    Article  CAS  PubMed  Google Scholar 

  63. Claassen J, Jette N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–65.

    Article  CAS  PubMed  Google Scholar 

  64. Vespa PM, O’Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60:1441–6.

    Article  CAS  PubMed  Google Scholar 

  65. Gross BA, Smith ER, Scott RM, Orbach DB. Intracranial aneurysms in the youngest patients: characteristics and treatment challenges. Pediatr Neurosurg. 2015;50:18–25.

    Article  PubMed  Google Scholar 

  66. Garg K, Singh PK, Sharma BS, et al. Pediatric intracranial aneurysms–our experience and review of literature. Childs Nerv Syst. 2014;30:873–83.

    Article  PubMed  Google Scholar 

  67. Heffren J, McIntosh AM, Reiter PD. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children. Pediatr Neurol. 2015;52:356–60.

    Article  PubMed  Google Scholar 

  68. Philip S, Chaiwat O, Udomphorn Y, et al. Variation in cerebral blood flow velocity with cerebral perfusion pressure > 40 mm Hg in 42 children with severe traumatic brain injury. Crit Care Med. 2009;37:2973–8.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Vavilala MS, Kincaid MS, Muangman SL, Suz P, Rozet I, Lam AM. Gender differences in cerebral blood flow velocity and autoregulation between the anterior and posterior circulations in healthy children. Pediatr Res. 2005;58:574–8.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Hoffman CE, Santillan A, Rotman L, Gobin YP, Souweidane MM. Complications of cerebral angiography in children younger than 3 years of age. J Neurosurg Pediatr. 2014;13:414–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Bldg 1, Room 101, Zuckerberg San Francisco General Hospital, University of California, 1001 Potrero Avenue, San Franciso, CA, 94110, USA

    J. Claude Hemphill III

  2. Department of Anesthesiology, University of California, San Diego, CA, USA

    Arthur Lam

Authors
  1. J. Claude Hemphill III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arthur Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Claude Hemphill III.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Claude Hemphill, J., Lam, A. Emergency Neurological Life Support: Intracerebral Hemorrhage. Neurocrit Care 27 (Suppl 1), 89–101 (2017). https://doi.org/10.1007/s12028-017-0453-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-017-0453-0

Keywords

Search

Navigation